Nisa Investment Advisors
ATYR

Nisa Investment Advisors’s aTyr Pharma ATYR Stock Holding History

Nisa Investment Advisors’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5 Sell
8
-966
-99% -$631 ﹤0.01% 3093
2026
Q1 		$760 Buy
+974
New +$822 ﹤0.01% 2795
2025
Q3 		– Sell
-1,203
Closed -$6.1K – 3109
2025
Q2 		$6.1K Buy
+1,203
New +$4.73K ﹤0.01% 2408

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nisa Investment Advisors's ATYR Position: Q2 2026 in Review

Nisa Investment Advisors reduced its aTyr Pharma (ATYR) stake by 99% in Q2 2026, selling an estimated $631 and leaving 8 shares worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #3093.

Nisa Investment Advisors first reported a position in ATYR in Q2 2025 and has held it in 3 quarters since. The position peaked at $6.1K in Q2 2025. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Nisa Investment Advisors held 8 shares of aTyr Pharma worth $5 as of Q2 2026.
  • Nisa Investment Advisors sold 966 aTyr Pharma shares in Q2 2026, an estimated $631.
  • aTyr Pharma made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #3093 holding.
  • Nisa Investment Advisors first reported a position in aTyr Pharma in Q2 2025 and has held it in 3 quarters since.
  • Nisa Investment Advisors's aTyr Pharma position peaked at $6.1K in Q2 2025.
  • 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.